Golinelli Gloria, Toso Andrea, Rosa Maria Silvia, Valletti Paolo Aluffi, Pia Francesco
Division of Ear Nose and Throat Department-Head and Neck Surgery, University of Piemonte Orientale "A. Avogadro," Corso Mazzini, Novara, Italy.
J Craniofac Surg. 2018 May;29(3):e331-e333. doi: 10.1097/SCS.0000000000004448.
Skull base metastases are extremely rare. The authors report a case of a 65-year-old man who presented with a headache and diplopia secondary to a skull base metastasis from occult renal cell carcinoma. Since there were no other systemic metastases, radical nephrectomy and radiotherapy of the unresectable skull base location were performed. He subsequently received immunotherapy with sunitinib, everolimus, and sorafenib with local and systemic control of the disease after 53 months from surgery. When metastasis is unresectable radical nephrectomy and radiotherapy aimed at the metastasis may be of benefit improving quality of life. Immunotherapy may provide alternative treatment strategies improving the outcomes of patients affected by this rare pathology with historically poor prognosis.
颅底转移极为罕见。作者报告了一例65岁男性患者,因隐匿性肾细胞癌颅底转移继发头痛和复视。由于无其他全身转移,遂行根治性肾切除术,并对无法切除的颅底部位进行放疗。术后53个月,他随后接受了舒尼替尼、依维莫司和索拉非尼免疫治疗,疾病得到局部和全身控制。当转移灶无法切除时,根治性肾切除术及针对转移灶的放疗可能有助于改善生活质量。免疫治疗可能提供替代治疗策略,改善这种预后历来较差的罕见疾病患者的治疗效果。